XINT (XINT) News
Follow XINT (XINT) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 5 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Xintela to use MSEK 30 convertible loan to repay prior MSEK 20 loan
Xintela raised a convertible loan of MSEK 30 from its main owner Flerie Invest in June to fully repay a MSEK 20 loan from Fenja Capital tied to the 2025 capital raise.
EQUITY | Sep 03, 2026, 07:47 AM UTC
L
Sweden's Xintela Q2 loss narrows as income rises, costs drop
Sweden's Xintela Q2 loss narrows as income rises, costs drop
EQUITY | Aug 28, 2026, 08:48 AM UTC
L
Xintela Q2 income up to SEK 1,317
Xintela reported Q2 income up at SEK 1,317.
EQUITY | Aug 28, 2026, 08:46 AM UTC
M
XINT Q2 2026 higher sales, XSTEM clinical progress, stronger financing
XINT reported Q2 2026 higher sales, clinical progress for XSTEM, and strengthened financing.
EQUITY | Aug 28, 2026, 08:42 AM UTC
L
Xintela AB files interim report for Jan–Jun 2026
Xintela AB released its interim report for January to June 2026.
EQUITY | Aug 28, 2026, 08:40 AM UTC